Tariffs/Trade
Senate Democrats are set to introduce legislation requiring US Health Secretary RFK Jr. to disclose terms of the Trump administration's confidential "most favoured nation" drug pricing deals with 16 pharma companies, according to Axios
News detail
The bill stands little chance of advancing, Axios says, but challenges administration transparency Democrats argue that the deals offer minimal patient savings, and largely exclude Medicare and private insurance recipients
What do investors think?
Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactionsStockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.